SCM
NEXI

Suvretta Capital Management’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Suvretta Capital Management’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,769
Closed -$5.21M – 116
2021
Q3 		$5.21M Sell
13,769
-861
-6% -$289K 0.09% 78
2021
Q2 		$5.97M Sell
14,630
-8,541
-37% -$3.93M 0.09% 89
2021
Q1 		$11.1M Buy
+23,171
New +$12.6M 0.16% 71

Other funds holding NEXI

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Suvretta Capital Management's NEXI Position: Q4 2021 in Review

Suvretta Capital Management sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2021, closing a stake of 13,769 shares — an estimated $5.21M sold.

Suvretta Capital Management first reported a position in NEXI in Q1 2021 and held it in 3 quarters. The position peaked at $11.1M in Q1 2021. 46 funds tracked by Wall St. Rank hold NEXI as of Q4 2021.

  • Suvretta Capital Management reported no remaining NexImmune, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Suvretta Capital Management sold 13,769 NexImmune, Inc. Common Stock shares in Q4 2021, an estimated $5.21M.
  • Suvretta Capital Management first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Suvretta Capital Management's NexImmune, Inc. Common Stock position peaked at $11.1M in Q1 2021.
  • 46 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2021.

Based on Suvretta Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.